MiNK Therapeutics to Report Fourth Quarter & Full Year 2021 Financial Results and Business Update
The financial report and an update on business progress will be released through a press release and online distribution networks and available on the investor section of the company’s website.
This press release contains forward-looking statements that are based on management's beliefs and are made pursuant to the safe harbor provisions of the federal securities laws. Forward-looking statements include, but are not limited to, statements concerning the therapeutic potential of iNKT cells to treat cancer and other diseases, and plans relating to the discovery, development, manufacture and commercialization of iNKT cell therapies. These forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially. These risks and uncertainties include, among others, the factors described under the Risk Factors section of our most recent Quarterly Report on Form 10-Q and a recent S-1 Registration Statement filed with the
Source: MiNK Therapeutics